Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
Auditor change
|
|
Cellular Biomedicine Group, Inc. (CBMG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/19/2021 |
SC 13D/A
| Liu Tony reports a 0% stake in Cellular Biomedicine Group, Inc. |
| 08/12/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/12/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/24/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/24/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/24/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/01/2020 |
SC 13D/A
| Sailing Capital Overseas Investments Fund, LP reports a 8.9% stake in Cellular Biomedicine Group, Inc. |
| 04/01/2020 |
SC 13D/A
| TF Venture Capital Management Co., Ltd. reports a 1.8% stake in Cellular Biomedicine Group, Inc. |
| 04/01/2020 |
SC 13D/A
| Liu Tony reports a 5.4% stake in Cellular Biomedicine Group, Inc. |
| 03/31/2020 |
SC 13D/A
| Dangdal International Group Co. Ltd reports a 11.8% stake in Cellular Biomedicine Group, Inc. |
| 03/30/2020 |
SC 13D/A
| Hillhouse Capital Advisors, Ltd. reports a 1.2% stake in Cellular Biomedicine Group, Inc. |
| 02/24/2020 |
SC 13D/A
| Dangdal International Group Co. Ltd reports a 11.8% stake in Cellular Biomedicine Group, Inc. |
| 02/21/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/21/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/21/2020 |
SC 13D/A
| Sailing Capital Overseas Investments Fund, LP reports a 8.9% stake in Cellular Biomedicine Group, Inc. |
| 02/21/2020 |
SC 13D/A
| Liu Tony reports a 5.7% stake in Cellular Biomedicine Group, Inc. |
| 01/31/2020 |
SC 13D/A
| Dangdal International Group Co. Ltd reports a 11.8% stake in Cellular Biomedicine Group, Inc. |
| 01/30/2020 |
SC 13D/A
| Liu Tony reports a 5.3% stake in Cellular Biomedicine Group, Inc. |
| 01/30/2020 |
SC 13D/A
| Hillhouse Capital Advisors, Ltd. reports a 1.2% stake in Cellular Biomedicine Group, Inc. |
| 11/18/2019 |
SC 13D/A
| Dangdal International Group Co. Ltd reports a 11.8% stake in Cellular Biomedicine Group, Inc. |
| 12/10/2018 |
SC 13D/A
| Dangdal International Group Co. Ltd reports a 12.3% stake in Cellular Biomedicine Group, Inc. |
| 11/25/2015 |
SC 13D/A
| Global Health Investment Holdings Ltd. reports a 0% stake in Cellular Biomedicine Group, Inc. |
| 08/09/2013 |
SC 13D/A
| Wong Keith reports a 8.4% stake in CELLULAR BIOMEDICINE GROUP, INC. |
| 05/07/2013 |
SC 13D/A
| Wong Keith reports a 8.9% stake in CELLULAR BIOMEDICINE GROUP, INC. |
|
|